AbbVie takes on cystic fibrosis, providing 40 grants to students


AbbVie yesterday announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or graduate school education during the 2014-2015 school year through the AbbVie CF Scholarship program. Voting for two of the 40 winners to earn the title of 2014 Thriving Undergraduate or Graduate Scholar is now open to the public at until September 15.

Continue reading

Corporate Venture Capital Bolsters Biotech Startup Community, and Other Investment Trends


Medical device companies are having a much harder time raising early-stage venture capital than biotech and pharma, according to a recent Silicon Valley Bank report.

“On the Series A side of things, biotech is a pretty stable area right now, but devices have some significant issues in trying to find ventures to support Series A company creation,” said Jonathon Norris, the author of “Trends in Healthcare: Investments and Exits.”

Continue reading

Docs advocate for novel biosimilar names


Ever since the FDA drafted a set of rules for biosimilars in 2012, a debate has been raging over whether those drugs should carry the same generic names as the products they emulate. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have different names than branded biotech drugs.

Continue reading

Abbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions

Abbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi–phased approach, the tests would be developed for Abbott’s i–STAT® System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members.

Continue reading

2014 University of Chicago Commencement Speaker,Kathryn Gould: Advice from one of the first women in venture capital

This article originally appeared on VentureBeat



I met Kathryn Gould longer ago than either of us want to admit.

Kathryn has been the founding VP of Marketing of Oracle, a successful recruiter, a world class venture capitalist, a co-founder of a venture capital firm, a great board member, one of my mentors and most importantly a wonderful friend.

Continue reading